Mackenzie L. Pater, PhD

Mackenzie L. Pater, PhD has a diverse work experience spanning over several years. Mackenzie L. is currently serving as the Executive Director of Portfolio Management at CinRx Pharma, where they are responsible for managing the company's portfolio of biotech companies. Mackenzie L. joined CinRx in 2020 as the Senior Director of Clinical Operations, where they oversaw various therapeutic programs and played a crucial role in raising funds for both CinRx and its subsidiary companies.

Prior to their role at CinRx, Mackenzie worked at CTI Clinical Trial and Consulting Services from 2015 to 2019 as a Project Manager. Mackenzie L. led multiple programs for rare and orphan diseases, including a global phase 3 program that supported the submission of a BLA. Mackenzie L. also supported the business development teams by streamlining communication and optimizing processes.

Before their industry experience, Mackenzie served as an NIH Pre-doctoral Fellow and Graduate Assistant at the University of Illinois at Chicago from 2011 to 2015. Mackenzie L. also worked as a Graduate Assistant at Wake Forest University from 2009 to 2011. Additionally, they gained research experience as a Research Scientist at the United States Army Research Institute for Environmental Medicine from 2008 to 2009 and as an Undergraduate Research Assistant at the University of Dayton from 2007 to 2008.

Mackenzie L. Pater, PhD has an extensive education history. Mackenzie L. began their academic journey at the University of Dayton from 2005 to 2009, where they earned a Bachelor's degree in Pre-Physical Therapy Studies. Following their undergraduate studies, they pursued further education at Wake Forest University from 2009 to 2011, obtaining a Master's degree in Exercise Physiology. Mackenzie L.'spassion for research and biomechanics led their to enroll in the University of Illinois Chicago from 2011 to 2015, where they completed their Doctor of Philosophy (Ph.D.) in Biomechanics. Most recently, Mackenzie has been enrolled at Xavier University, focusing on a Master of Business Administration (MBA), which they are expected to complete in 2023. With their diverse educational background and expertise in biomechanics and exercise physiology, Mackenzie is well-equipped to make significant contributions in their field.